Sanofi, Regeneron Rheumatoid Arthritis Drug Proves Ineffective Against COVID-19
Sanofi SA (NASDAQ: SNY) announced Tuesday that its rheumatoid arthritis drug Kevzara, developed in partnership with Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), isn't effective against COVID-19.